PPGN.SW
Price:
$24.85
Market Cap:
$876.65M
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. T...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-04-28
Stock Exchange
SIX
Ticker
PPGN.SW
According to PolyPeptide Group AG’s latest financial reports and current stock price. The company's current Enterprise Value is 900.41M. This represents a change of 4.85% compared to the average of 858.73M of the last 4 quarters.
The mean historical Enterprise Value of PolyPeptide Group AG over the last ten years is 1.69B. The current 900.41M Enterprise Value has changed 5.24% with respect to the historical average. Over the past ten years (40 quarters), PPGN.SW's Enterprise Value was at its highest in in the December 2021 quarter at 4.26B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
1.69B
Median
1.70B
Minimum
639.29M
Maximum
4.12B
Discovering the peaks and valleys of PolyPeptide Group AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 134.80%
Maximum Annual Enterprise Value = 4.12B
Minimum Annual Increase = -79.92%
Minimum Annual Enterprise Value = 639.29M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.02B | 59.67% |
| 2023 | 639.29M | -22.71% |
| 2022 | 827.16M | -79.92% |
| 2021 | 4.12B | 134.80% |
| 2020 | 1.75B | 0.53% |
| 2019 | 1.74B | 2.68% |
The current Enterprise Value of PolyPeptide Group AG (PPGN.SW) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
829.07M
5-year avg
1.67B
10-year avg
1.69B
PolyPeptide Group AG’s Enterprise Value is less than Idorsia Ltd (2.07B), greater than Basilea Pharmaceutica AG (623.63M), less than Cosmo Pharmaceuticals N.V. (1.61B), less than Medartis Holding AG (1.05B), less than SKAN Group AG (1.06B), less than Aevis Victoria S.A. (1.26B), greater than IVF Hartmann Holding AG (240.06M), greater than DocMorris AG (450.65M), greater than COLTENE Holding AG (348.86M), less than Kuros Biosciences AG (1.10B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.07B | $833.25M | |
| 623.63M | $655.21M | |
| 1.61B | $1.55B | |
| 1.05B | $1.05B | |
| 1.06B | $1.10B | |
| 1.26B | $1.08B | |
| 240.06M | $333.60M | |
| 450.65M | $290.38M | |
| 348.86M | $314.31M | |
| 1.10B | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PolyPeptide Group AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PolyPeptide Group AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is PolyPeptide Group AG's Enterprise Value?
What is the highest Enterprise Value for PolyPeptide Group AG (PPGN.SW)?
What is the 3-year average Enterprise Value for PolyPeptide Group AG (PPGN.SW)?
What is the 5-year average Enterprise Value for PolyPeptide Group AG (PPGN.SW)?
How does the current Enterprise Value for PolyPeptide Group AG (PPGN.SW) compare to its historical average?